Article
22 Oct 2026
Eli Lilly’s Retatrutide Lawsuits: What Pharmacies, Telemedicine Companies And Online Retailers Need To Know
CONTRIBUTING SINCE MARCH 2011
Buchanan Ingersoll & Rooney PC
With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
POPULAR TOPICS
Food, Drugs, Healthcare, Life Sciences
International Law
Employment and HR
Intellectual Property
Technology
Buchanan Ingersoll & Rooney PC are most popular:
- with readers working within the Healthcare, Technology and Media & Information industries
DETAILS
United States
+1 412 562 8800
Union Trust Building
501 Grant Street
Suite 200
Pittsburgh
United States
Contact Firm
COMPANY CONTENT
Article
22 Oct 2026
FDA Submits Interim Peptide Compounding Policy For White House Review: What Pharmacies Should Know
Article
22 Oct 2026
The House Energy And Commerce Committee’s Fraud Report And The Direction Of Health Care Enforcement
Article
20 Oct 2026
Hospital Mergers And In-House Pharmacies: Licensing, Payor Contracting And Operational Issues That Cannot Wait Until Closing
Article
15 Oct 2026
FDA Peptide Compounding Policy: What A Temporary Enforcement Reprieve Could Mean For Pharmacies
Article
15 Oct 2026
Allegheny County Board Of Health Passes Paid Parental Leave Proposal
Article
13 Oct 2026
PBM Audits And Network Terminations: Preparing Pharmacies For Heightened Year-End Scrutiny
Article
12 Oct 2026
Satius Holding v. Samsung Electronics: Impossible Claims Can Still Be Definite—But Lack Enablement
Article
08 Oct 2026
California Proposition 65: What Retailers Need to Know About Warning Requirements and 60-Day Notices
Article
08 Oct 2026
Defense Counterintelligence And Security Agency Report Reveals Threats To U.S. Cleared Industry
Article
08 Oct 2026
SEC Proposes Rescission Of Rule 14a-8 And Amendments To Rule 14a-4
Article
07 Oct 2026
Proposed IRS And Treasury Rules Tie Racial Nondiscrimination To Tax-Exempt Status For Private Schools And Universities
Article
05 Oct 2026
CIPA Reform Gives Companies A Carve-Out But No Cure: Plaintiffs Pivot As SB 690 Is Signed Into Law
Article
30 Sep 2026
Senate Passes Bipartisan Protect College Sports Act
Article
28 Sep 2026
FDA Warning Letter To Empower Pharmacy And What It Means For 503A Compounding Pharmacies
Article
25 Sep 2026
Allegheny County Modifies Paid Parental Leave Proposal
Article
23 Sep 2026
USTR Seeks Comments on Foreign Trade Barriers for 2027 Trade Report
Article
22 Sep 2026
Update On CAPE Phase 3 Duty Refunds From U.S. Customs And Border Protection
Article
22 Sep 2026
Buchanan’s PBM & Pharmacy Practice Group Reduce PBM Audit Findings By 100%
Article
22 Sep 2026
As The Protect College Sports Act Heads To The Senate Floor, What Institutions, Collectives And MMR Partners Should Watch
AWARDS
